Krystal Accounts Payable from 2010 to 2025

KRYS Stock  USD 192.30  2.14  1.10%   
Krystal Biotech Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 2.8 M in 2025. Accounts Payable is the amount Krystal Biotech owes to suppliers or vendors for products or services received but not yet paid for. It represents Krystal Biotech's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2016-12-31
Previous Quarter
5.6 M
Current Value
M
Quarterly Volatility
2.7 M
 
Covid
Check Krystal Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Krystal Biotech's main balance sheet or income statement drivers, such as Net Interest Income of 31.1 M, Interest Income of 31.1 M or Depreciation And Amortization of 7 M, as well as many indicators such as Price To Sales Ratio of 14.65, Dividend Yield of 0.0 or PTB Ratio of 4.5. Krystal financial statements analysis is a perfect complement when working with Krystal Biotech Valuation or Volatility modules.
  
Check out the analysis of Krystal Biotech Correlation against competitors.
For more information on how to buy Krystal Stock please use our How to Invest in Krystal Biotech guide.

Latest Krystal Biotech's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Krystal Biotech over the last few years. An accounting item on the balance sheet that represents Krystal Biotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Krystal Biotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Krystal Biotech's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Krystal Biotech's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Krystal Accounts Payable Regression Statistics

Arithmetic Mean1,640,517
Geometric Mean350,775
Coefficient Of Variation145.44
Mean Deviation1,788,272
Median724,000
Standard Deviation2,385,966
Sample Variance5.7T
Range8.4M
R-Value0.68
Mean Square Error3.2T
R-Squared0.47
Significance0
Slope342,609
Total Sum of Squares85.4T

Krystal Accounts Payable History

20252.8 M
2024M
20231.8 M
2022M
20218.4 M
20202.1 M
2019724 K

About Krystal Biotech Financial Statements

Krystal Biotech shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Krystal Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Krystal Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Krystal Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts PayableM2.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Krystal Stock Analysis

When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.